Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
04 Avril 2023 - 1:46PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of April 2023
Commission File Number: 001-37452
CELYAD ONCOLOGY SA
(Translation of registrants name into English)
Rue Edouard
Belin 2
1435 Mont-Saint-Guibert, Belgium
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Celyad Oncology SA
On April 4, 2023, Celyad Oncology SA (the Company) published the convening notice for the Ordinary General Meeting of Shareholders to
be held on May 5, 2023, at 2:00 p.m. (Central European time). A copy of the convening notice is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
In addition, on April 4, 2023, the Company published a special report in accordance with Article 7:228 of the Belgian Companies and Associations
Code. A copy of the special report is attached hereto as Exhibit 99.2 and is incorporated herein by reference.
The information contained in this
Current Report on Form 6-K, including Exhibits 99.1 and 99.2, is hereby incorporated by reference into the Companys Registration Statements on Forms F-3 (File No. 333-248464) and S-8 (File No. 333-220737).
EXHIBITS
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELYAD ONCOLOGY SA |
|
|
|
|
Date: April 4, 2023 |
|
|
|
By: |
|
/s/ Michel Lussier |
|
|
|
|
|
|
Michel Lussier |
|
|
|
|
|
|
Interim Chief Executive Officer |
Celyad (CE) (USOTC:CLYYF)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Celyad (CE) (USOTC:CLYYF)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024
Real-Time news about Celyad SA (CE) (OTCMarkets): 0 recent articles
Plus d'articles sur Celyad Oncology Sa